These findings suggested that 8a, as a SIRT6 inhibitor, may inhibit the proliferation of pancreatic cancer cells by inhibiting the PI3K/AKT/mTOR and ERK signaling pathways. Here, SIRT6 is linked to pancreatic neoplasm.